Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:
| Indexado |
|
||||
| DOI | 10.1038/CDD.2011.189 | ||||
| Año | 2012 | ||||
| Tipo | artículo de investigación |
Citas Totales
Autores Afiliación Chile
Instituciones Chile
% Participación
Internacional
Autores
Afiliación Extranjera
Instituciones
Extranjeras
Transmembrane BAX inhibitor motif-containing (TMBIM)-6, also known as BAX-inhibitor 1 (BI-1), is an anti-apoptotic protein that belongs to a putative family of highly conserved and poorly characterized genes. Here we report the function of TMBIM3/GRINA in the control of cell death by endoplasmic reticulum (ER) stress. Tmbim3 mRNA levels are strongly upregulated in cellular and animal models of ER stress, controlled by the PERK signaling branch of the unfolded protein response. TMBIM3/GRINA synergies with TMBIM6/BI-1 in the modulation of ER calcium homeostasis and apoptosis, associated with physical interactions with inositol trisphosphate receptors. Loss-of-function studies in D. melanogaster demonstrated that TMBIM3/GRINA and TMBIM6/BI-1 have synergistic activities against ER stress in vivo. Similarly, manipulation of TMBIM3/GRINA levels in zebrafish embryos revealed an essential role in the control of apoptosis during neuronal development and in experimental models of ER stress. These findings suggest the existence of a conserved group of functionally related cell death regulators across species beyond the BCL-2 family of proteins operating at the ER membrane. Cell Death and Differentiation (2012) 19, 1013-1026; doi:10.1038/cdd.2011.189; published online 13 January 2012
| Ord. | Autor | Género | Institución - País |
|---|---|---|---|
| 1 | Rojas-Rivera, D. | Hombre |
Universidad de Chile - Chile
|
| 2 | ARMISEN-YANEZ, RICARDO AMADO | Hombre |
Universidad de Chile - Chile
|
| 3 | COLOMBO-FLORES, ALICIA ANGELINA | Mujer |
Universidad de Chile - Chile
|
| 4 | MARTINEZ, -BRAVO, GABRIELA RAQUEL ELENA | Mujer |
Universidad de Chile - Chile
|
| 5 | Eguiguren, A. L. | Mujer |
Universidad de Chile - Chile
|
| 6 | DIAZ-CRUZ, ALEXIS RODRIGO | Mujer |
Universidad de Chile - Chile
|
| 7 | Kiviluoto, Santeri | Hombre |
Katholieke Univ Leuven - Bélgica
KU Leuven - Bélgica |
| 8 | RODRIGUEZ-GONZALEZ, DIEGO ALEJANDRO | Hombre |
Universidad de Chile - Chile
|
| 9 | Patron, M. | - |
Univ Padua - Italia
Natl Res Council CNR - Italia Università degli Studi di Padova - Italia |
| 10 | Rizzuto, Rosario | Hombre |
Univ Padua - Italia
Natl Res Council CNR - Italia Università degli Studi di Padova - Italia |
| 11 | Bultynck, Geert | Hombre |
Katholieke Univ Leuven - Bélgica
KU Leuven - Bélgica |
| 12 | CONCHA-NORDEMANN, MIGUEL LUIS | Hombre |
Universidad de Chile - Chile
|
| 13 | JARA-WILDE, J. | Mujer |
Universidad de Chile - Chile
|
| 14 | STUTZIN-SCHOTTLANDER, ANDRES JOAQUIN | Hombre |
Universidad de Chile - Chile
|
| 15 | HETZ-FLORES, CLAUDIO ANDRES | Hombre |
Universidad de Chile - Chile
Harvard University - Estados Unidos Harvard T.H. Chan School of Public Health - Estados Unidos |
| Fuente |
|---|
| FONDECYT |
| CONICYT |
| FONDAP |
| Fondo Nacional de Desarrollo Científico y Tecnológico |
| Comisión Nacional de Investigación Científica y Tecnológica |
| Millennium Nucleus |
| Howard Hughes Medical Institute |
| International Center for Genetic Engineering and Biotechnology |
| International Centre for Genetic Engineering and Biotechnology |
| Alzheimer's Association |
| Muscular Dystrophy Association |
| ICGEB |
| Comisión Nacional de Investigación CientÃfica y Tecnológica |
| Seventh Framework Programme |
| Fondo Nacional de Desarrollo CientÃfico, Tecnológico y de Innovación Tecnológica |
| Michael J Fox Foundation for Parkinson Research |
| Michael J. Fox Foundation for Parkinson's Research |
| Alzheimer’s Association |
| Millennium Initiative |
| North American Spine Society |
| INTNL |
| Agradecimiento |
|---|
| We apologize to all colleagues whose work could not be cited owing to space limitations. We thank David Ron for providing IRE1 alpha and PERK-deficient cells, Dr. Ann-Hwee Lee for providing and generating IRE1 alpha KO-reconstituted cells, and Dr. NirHacohen and the Broad Institute (Boston, MA, USA) for providing shRNA lentiviral constructs. We also thank Dr. John Reed for kindly providing bi-1<SUP>-/-</SUP> cells and Dr. Randal Kaufman for providing ATF6 alpha-deficient cells. We thank Peter Thielen for technical assistant in cloning. We thank Cecilia Zunigafor for his technical support with fluorescence-activated cell sorting analysis, Tomas Luyten for technical support with <SUP>45</SUP>Ca<SUP>2+</SUP>-flux assays and Jan Parys for helpful discussions. This work was supported by the FONDECYT no. 1100176, Alzheimer's Association, Muscular Dystrophy Association, Michael J Fox Foundation for Parkinson Research, North American Spine Society, and ICGEB (to CH); FONDECYT no. 1090272 (JS), FONDECYT no. 11090324(AC), Howard Hughes Medical Institute (INTNL 55005940), FONDECYT (1090242) and the Millennium Initiative (ICM P07-048-F) (MC); FONDECYT no. 3100033 (DR); CONICYT Doctoral fellowship (DR-R, GM); UCH-0606 (DR-R); CONICYT no. 24090143 (DR-R), Millennium Nucleus no. P07-048-F (CH, MC, JS); FONDAP Grant no. 15010006 (RA, AS and CH); Grants STRT1/10/044 (GB). |
| Acknowledgements. We apologize to all colleagues whose work could not be cited owing to space limitations. We thank David Ron for providing IRE1a and PERK-deficient cells, Dr. Ann-Hwee Lee for providing and generating IRE1a KO-reconstituted cells, and Dr. NirHacohen and the Broad Institute (Boston, MA, USA) for providing shRNA lentiviral constructs. We also thank Dr. John Reed for kindly providing bi-1−/−cells and Dr. Randal Kaufman for providing ATF6a-deficient cells. We thank Peter Thielen for technical assistant in cloning. We thank Cecilia Zuñigafor for his technical support with fluorescence-activated cell sorting analysis, Tomas Luyten for technical support with 45Ca2+-flux assays and Jan Parys for helpful discussions. This work was supported by the FONDECYT no. 1100176, Alzheimer’s Association, Muscular Dystrophy Association, Michael J Fox Foundation for Parkinson Research, North American Spine Society, and ICGEB (to CH); FONDECYT no.1090272 (JS), FONDECYT no. 11090324(AC), Howard Hughes Medical Institute (INTNL 55005940), FONDECYT (1090242) and the Millennium Initiative (ICM P07-048-F) (MC); FONDECYT no. 3100033 (DR); CONICYT Doctoral fellowship (DR-R, GM); UCH-0606 (DR-R); CONICYT no. 24090143 (DR-R), Millennium Nucleus no. P07-048-F (CH, MC, JS); FONDAP Grant no. 15010006 (RA, AS and CH); Grants STRT1/10/044 (GB). |